EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -1.355
March 31, 2026 -1.966
December 31, 2025 -8.521
September 30, 2025 -27.80
June 30, 2025 -82.27
March 31, 2025 -44.53
December 31, 2024 -18.90
September 30, 2024 -49.03
June 30, 2024 -46.76
March 31, 2024 -25.92
December 31, 2023 -375.25
September 30, 2023 -137.13
June 30, 2023 -30.08
March 31, 2023 -82.94
December 31, 2022 -53.54
September 30, 2022 -89.37
June 30, 2022 -132.98
March 31, 2022 -149.26
December 31, 2021 -205.42
September 30, 2021 -243.73
June 30, 2021 -331.61
March 31, 2021 -201.93
December 31, 2020 66.66
Date Value
September 30, 2020 -771.31
June 30, 2020 -1116.29
March 31, 2020 -410.13
December 31, 2019 -899.18
September 30, 2019 -257.44
June 30, 2019 -1025.41
March 31, 2019 -3434.24
December 31, 2018 -2050.46
September 30, 2018 419.12
June 30, 2018 -619.19
March 31, 2018 -636.12
December 31, 2017 -19618.15
September 30, 2017 -11788.23
June 30, 2017 -12428.45
March 31, 2017 -12825.00
December 31, 2016 -18991.26
September 30, 2016 -5643.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 -913.14
September 30, 2015 -741.80
June 30, 2015 -263.68
March 31, 2015 -413.48

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. -0.0004
Health Catalyst, Inc. -0.5481
GoodRx Holdings, Inc. 0.0245
Claritev Corp. -3.491
iSpecimen, Inc. -0.9773